CHINA PHARMA HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

About this update from China Pharma Holdings, Inc.

Item 7.01 Regulation FD Disclosure On February 24, 2023 , China Pharma Holdings, Inc. issued a press release, included herewith as Exhibit 99.1, announcing that it expects to implement a 1-for-10 reverse stock split effective Monday, March 6, 2023 , with trading to begin on a split-adjusted basis at the market open on that day. The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, except as expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits (d) Exhibits. 99.1 Press Release, dated February 24, 2023 . 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL) © Edgar Online, source Glimpses

View stock analysis, news, and events for China Pharma Holdings, Inc.